Hypoxia and aging: molecular mechanisms, diseases, and therapeutic targets

被引:2
|
作者
Nisar, Ayesha [1 ,2 ,3 ]
Khan, Sawar [4 ,5 ]
Li, Wen [6 ]
Hu, Li [1 ,2 ,3 ]
Samarawickrama, Priyadarshani Nadeeshika [1 ,2 ,3 ]
Gold, Naheemat Modupeola [1 ,2 ,3 ]
Zi, Meiting [1 ,3 ]
Mehmood, Sardar Azhar [7 ]
Miao, Jiarong [8 ]
He, Yonghan [1 ,2 ,3 ]
机构
[1] Chinese Acad Sci, Kunming Inst Zool, Key Lab Genet Evolut & Anim Models, KIZ CUHK Joint Lab Bioresources & Mol Res Common D, Kunming, Yunnan, Peoples R China
[2] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Peoples R China
[3] Chinese Acad Sci, Kunming Inst Zool, Key Lab Hlth Aging Res Yunnan Prov, Kunming, Yunnan, Peoples R China
[4] Cent South Univ, Sch Life Sci, Dept Cell Biol, Changsha, Hunan, Peoples R China
[5] Univ Lahore, Inst Mol Biol & Biotechnol, Lahore, Pakistan
[6] Dali Univ, Affiliated Hosp 2, Peoples Hosp Yunnan Prov 3, Dept Endocrinol, Kunming, Yunnan, Peoples R China
[7] Hazara Univ, Dept Zool, Mansehra, Pakistan
[8] Kunming Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Kunming, Yunnan, Peoples R China
来源
MEDCOMM | 2024年 / 5卷 / 11期
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
age-related disease; aging; hypoxia; mechanism; therapeutic target; NF-KAPPA-B; CHRONIC INTERMITTENT HYPOXIA; INDUCED TAU PHOSPHORYLATION; ALTITUDE CEREBRAL EDEMA; OBSTRUCTIVE SLEEP-APNEA; SENESCENT CELLS; CELLULAR SENESCENCE; ALZHEIMERS-DISEASE; INDUCIBLE FACTORS; STEM-CELLS;
D O I
10.1002/mco2.786
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aging is a complex biological process characterized by the gradual decline of cellular functions, increased susceptibility to diseases, and impaired stress responses. Hypoxia, defined as reduced oxygen availability, is a critical factor that influences aging through molecular pathways involving hypoxia-inducible factors (HIFs), oxidative stress, inflammation, and epigenetic modifications. This review explores the interconnected roles of hypoxia in aging, highlighting how hypoxic conditions exacerbate cellular damage, promote senescence, and contribute to age-related pathologies, including cardiovascular diseases, neurodegenerative disorders, cancer, metabolic dysfunctions, and pulmonary conditions. By examining the molecular mechanisms linking hypoxia to aging, we identify key pathways that serve as potential therapeutic targets. Emerging interventions such as HIF modulators, antioxidants, senolytics, and lifestyle modifications hold promise in mitigating the adverse effects of hypoxia on aging tissues. However, challenges such as the heterogeneity of aging, lack of reliable biomarkers, and safety concerns regarding hypoxia-targeted therapies remain. This review emphasizes the need for personalized approaches and advanced technologies to develop effective antiaging interventions. By integrating current knowledge, this review provides a comprehensive framework that underscores the importance of targeting hypoxia-induced pathways to enhance healthy aging and reduce the burden of age-related diseases. Aging involves the decline of cellular functions and increased disease susceptibility. Hypoxia, or reduced oxygen availability, accelerates aging by influencing pathways like hypoxia-inducible factors (HIFs), oxidative stress, and inflammation. This review highlights how hypoxia exacerbates cellular damage, promotes senescence, and contributes to age-related diseases. Emerging therapies, such as HIF modulators and senolytics, show promise in mitigating hypoxia's impact on aging. image
引用
收藏
页数:27
相关论文
共 50 条
  • [41] Proteostasis unbalance in prion diseases: Mechanisms of neurodegeneration and therapeutic targets
    Thellung, Stefano
    Corsaro, Alessandro
    Dellacasagrande, Irene
    Nizzari, Mario
    Zambito, Martina
    Florio, Tullio
    FRONTIERS IN NEUROSCIENCE, 2022, 16
  • [42] Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets
    Maharjan, Chandra K.
    Ear, Po Hien
    Tran, Catherine G.
    Howe, James R.
    Chandrasekharan, Chandrikha
    Quelle, Dawn E.
    CANCERS, 2021, 13 (20)
  • [43] Molecular mechanisms and therapeutic targets for diabetic kidney disease
    Tuttle, Katherine R.
    Agarwal, Rajiv
    Alpers, Charles E.
    Bakris, George L.
    Brosius, Frank C.
    Kolkhof, Peter
    Uribarri, Jaime
    KIDNEY INTERNATIONAL, 2022, 102 (02) : 248 - 260
  • [44] Molecular mechanisms and therapeutic targets in pediatric brain tumors
    Liu, Kun-Wei
    Pajtler, Kristian W.
    Worst, Barbara C.
    Pfister, Stefan M.
    Wechsler-Reya, Robert J.
    SCIENCE SIGNALING, 2017, 10 (470)
  • [45] Histone Modification in NSCLC: Molecular Mechanisms and Therapeutic Targets
    Bajbouj, Khuloud
    Al-Ali, Abeer
    Ramakrishnan, Rakhee K.
    Saber-Ayad, Maha
    Hamid, Qutayba
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)
  • [46] Molecular Mechanisms and Potential Therapeutic Targets in Incisional Hernia
    Thankam, Finosh G.
    Palanikumar, Gunasekar
    Fitzgibbons, Robert J.
    Agrawal, Devendra K.
    JOURNAL OF SURGICAL RESEARCH, 2019, 236 : 134 - 143
  • [47] Signaling pathways in macrophages: molecular mechanisms and therapeutic targets
    Li, Ming
    Wang, Mengjie
    Wen, Yuanjia
    Zhang, Hongfei
    Zhao, Guang-Nian
    Gao, Qinglei
    MEDCOMM, 2023, 4 (05):
  • [48] Cellular senescence in cancer: molecular mechanisms and therapeutic targets
    Jin, Ping
    Duan, Xirui
    Li, Lei
    Zhou, Ping
    Zou, Cheng-Gang
    Xie, Ke
    MEDCOMM, 2024, 5 (05):
  • [49] Diabetic Nephropathy: Novel Molecular Mechanisms and Therapeutic Targets
    Zoja, Carlamaria
    Xinaris, Christodoulos
    Macconi, Daniela
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [50] The Role of Autophagy in Liver Diseases: Mechanisms and Potential Therapeutic Targets
    Cursio, Raffaele
    Colosetti, Pascal
    Codogno, Patrice
    Cuervo, Ana Maria
    Shen, Han-Ming
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015